135 related articles for article (PubMed ID: 34786823)
21. Radiologic placement of subcutaneous infusion chest ports for long-term central venous access.
Funaki B; Szymski GX; Hackworth CA; Rosenblum JD; Burke R; Chang T; Leef JA
AJR Am J Roentgenol; 1997 Nov; 169(5):1431-4. PubMed ID: 9353475
[TBL] [Abstract][Full Text] [Related]
22. Subcutaneous venous port implantation in adult patients: a single center experience.
Cil BE; Canyiğit M; Peynircioğlu B; Hazirolan T; Carkaci S; Cekirge S; Balkanci F
Diagn Interv Radiol; 2006 Jun; 12(2):93-8. PubMed ID: 16752357
[TBL] [Abstract][Full Text] [Related]
23. Utilization and Complications of Central Venous Access Devices in Oncology Patients.
Akhtar N; Lee L
Curr Oncol; 2021 Jan; 28(1):367-377. PubMed ID: 33435136
[TBL] [Abstract][Full Text] [Related]
24. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
[TBL] [Abstract][Full Text] [Related]
25. Experience with subcutaneous infusion ports in three hundred patients.
Brothers TE; Von Moll LK; Niederhuber JE; Roberts JA; Walker-Andrews S; Ensminger WD
Surg Gynecol Obstet; 1988 Apr; 166(4):295-301. PubMed ID: 3127896
[TBL] [Abstract][Full Text] [Related]
26. Portacaths are safe for long-term regular blood transfusion in children with sickle cell anaemia.
Bartram JL; O'Driscoll S; Kulasekararaj AG; Height SE; Dick M; Patel S; Rees DC
Arch Dis Child; 2011 Nov; 96(11):1082-4. PubMed ID: 20605863
[TBL] [Abstract][Full Text] [Related]
27. Upper body central venous catheters in pediatric cardiac surgery.
Miller JW; Vu DN; Chai PJ; Kreutzer JH; John JB; Vener DF; Jacobs JP
Paediatr Anaesth; 2013 Nov; 23(11):980-8. PubMed ID: 24088201
[TBL] [Abstract][Full Text] [Related]
28. Cathlink 20: a subcutaneous implanted central venous access device used in children with sickle cell disease on long-term erythrocytapheresis--a report of low complication rates.
Raj A; Bertolone S; Bond S; Burnett D; Denker A
Pediatr Blood Cancer; 2005 Jun; 44(7):669-72. PubMed ID: 15700248
[TBL] [Abstract][Full Text] [Related]
29. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients.
Mirro J; Rao BN; Stokes DC; Austin BA; Kumar M; Dahl GV; Colten M; Balas L; Rafferty M; Hancock M
J Clin Oncol; 1989 Feb; 7(2):214-22. PubMed ID: 2915237
[TBL] [Abstract][Full Text] [Related]
30. Complications Associated With Totally Implanted Venous Access Devices in the Arm Versus the Chest: A Short-Term Retrospective Study.
Pike S; Tan K; Burbridge B
Can Assoc Radiol J; 2022 Aug; 73(3):581-588. PubMed ID: 34911380
[TBL] [Abstract][Full Text] [Related]
31. Radiologic placement of implantable chest ports in pediatric patients.
Lorenz JM; Funaki B; Van Ha T; Leef JA
AJR Am J Roentgenol; 2001 Apr; 176(4):991-4. PubMed ID: 11264096
[TBL] [Abstract][Full Text] [Related]
32. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
[TBL] [Abstract][Full Text] [Related]
33. Infectious morbidity associated with long-term use of venous access devices in patients with cancer.
Groeger JS; Lucas AB; Thaler HT; Friedlander-Klar H; Brown AE; Kiehn TE; Armstrong D
Ann Intern Med; 1993 Dec; 119(12):1168-74. PubMed ID: 8239247
[TBL] [Abstract][Full Text] [Related]
34. Central venous catheter complications in sickle cell disease.
Jeng MR; Feusner J; Skibola C; Vichinsky E
Am J Hematol; 2002 Feb; 69(2):103-8. PubMed ID: 11835345
[TBL] [Abstract][Full Text] [Related]
35. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
Taxbro K; Hammarskjöld F; Thelin B; Lewin F; Hagman H; Hanberger H; Berg S
Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243
[TBL] [Abstract][Full Text] [Related]
36. Vascular access: choice and complications in European paediatric haemodialysis units.
Hayes WN; Watson AR; Callaghan N; Wright E; Stefanidis CJ;
Pediatr Nephrol; 2012 Jun; 27(6):999-1004. PubMed ID: 22205507
[TBL] [Abstract][Full Text] [Related]
37. Effect of catheter diameter on left innominate vein in breast cancer patients after totally implantable venous access port placement.
Song MG; Seo TS; Kim YH; Cho SB; Chung HH; Lee SH; Jung E
J Vasc Access; 2018 Nov; 19(6):615-619. PubMed ID: 29560786
[TBL] [Abstract][Full Text] [Related]
38. Complications of Central Venous Access Devices in Patients With Sickle Cell Disease and Thalassemia Major.
Ordóñez J; Del Cañizo A; Beléndez C; García-Morín M; Pérez-Egido L; Fanjul M; García-Casillas MA; Cerdá J; Peláez D; Bardón E; de Agustín JC; Cela E
J Pediatr Hematol Oncol; 2021 Jul; 43(5):e655-e660. PubMed ID: 33093353
[TBL] [Abstract][Full Text] [Related]
39. Outcome of 350 implanted chest ports placed by interventional radiologists.
Shetty PC; Mody MK; Kastan DJ; Sharma RP; Burke MW; Venugopal C; Burke TH
J Vasc Interv Radiol; 1997; 8(6):991-5. PubMed ID: 9399468
[TBL] [Abstract][Full Text] [Related]
40. Insertion of subcutaneous central venous infusion ports by interventional radiologists.
Struk DW; Bennett JD; Kozak RI
Can Assoc Radiol J; 1995 Feb; 46(1):32-6. PubMed ID: 7834483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
